Health management devices and methods

US11264133B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11264133-B2
Application numberUS-202117157611-A
CountryUS
Kind codeB2
Filing dateJan 25, 2021
Priority dateJun 21, 2007
Publication dateMar 1, 2022
Grant dateMar 1, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A healthcare provider receiving device for glucose data obtained from a plurality of patients of a healthcare provider, comprising: a wireless communication component configured to communicate with each of a plurality of glucose monitoring systems, each of the plurality of glucose monitoring systems comprising one or more data processing units coupled to a corresponding transcutaneous glucose sensor, each corresponding transcutaneous glucose sensor configured to be positioned at least in part in contact with a fluid under a skin layer of a patient of the plurality of patients of the healthcare provider, each one or more data processing units configured to generate glucose data of a corresponding patient of the plurality of patients from the corresponding transcutaneous glucose sensor, each one or more data processing units having a memory configured to store corresponding glucose data generated during an entire wear period of several days to weeks; a USB port; and one or more processors configured to, for each patient: cause an operational status of the corresponding glucose monitoring system to be displayed at the healthcare provider receiving device during the wear period, obtain the stored glucose data of the patient from the corresponding one or more data processing units, wherein the receiver does not allow the patient to view the stored glucose data such that the patient is blinded during the entire wear period, and transmit the glucose data of the patient to a healthcare provider computing device using the USB port. 2. The device of claim 1 , wherein the glucose data transmitted to the healthcare provider computing device comprises calibrated glucose data. 3. The device of claim 1 , wherein the one or more processors are further configured to transmit a unique identifier to the healthcare provider computing device, wherein the unique identifier is used by a remote server associate the glucose data with the corresponding patient of the plurality of patients. 4. The device of claim 3 , wherein the unique identifier comprises identification information of the one or more data processing units. 5. The device of claim 4 , wherein the unique identifier is encrypted. 6. The device of claim 1 , wherein the one or more processors are configured to check for errors in the transmitted glucose data using cyclic redundancy checks. 7. The device of claim 1 , wherein the operational status comprises an indication of system integrity. 8. The device of claim 1 , wherein the operational status comprises a duration of data collection. 9. The device of claim 1 , wherein the wireless communication component is configured to communicate with each of the plurality of glucose monitoring systems by a Bluetooth protocol. 10. A healthcare provider monitoring system for glucose data obtained from a plurality of patients of a healthcare provider, comprising: a plurality of glucose monitoring systems, each of the plurality of glucose monitoring systems comprising: a transcutaneous glucose sensor configured to be positioned at least in part in contact with a fluid under a skin layer of a patient of the plurality of patients of the healthcare provider, and one or more data processing units coupled to the transcutaneous glucose sensor and configured to generate glucose data from the transcutaneous glucose sensor, the one or more data processing units having a memory configured to store the glucose data generated during an entire wear period of several days to weeks, and a healthcare provider receiving device comprising: a wireless communication component configured to communicate with each of the plurality of glucose monitoring systems, a USB port, and one or more processors configured to, for each patient: cause an operational status of the corresponding glucose monitoring system to be displayed at the healthcare receiving device during the wear period, obtain the stored glucose data of the patient from the corresponding one or more data processing units, wherein the receiver does not allow the patient to view the stored glucose data such that the patient is blinded during the entire wear period, and transmit the glucose data of the patient to a healthcare provider computing device using the USB port. 11. The system of claim 10 , wherein the stored glucose data comprises calibrated glucose data. 12. The system of claim 10 , wherein the stored glucose data comprises uncalibrated glucose data, and the uncalibrated glucose data is transformed into calibrated glucose data using the one or more processors with no user intervention. 13. The system of claim 10 , wherein the stored glucose data comprises uncalibrated glucose data, and the uncalibrated glucose data is transformed into calibrated glucose data using the one or more processors without using an in vitro glucose test strip. 14. The system of claim 10 , wherein the glucose data transmitted to the healthcare provider computing device comprises calibrated glucose data. 15. The system of claim 10 , further comprising a remote server configured to receive the glucose data from the healthcare provider computing device via a network connection. 16. The system of claim 15 , wherein the remote server is configured to provide access to the glucose data or a report of the glucose data via a network connection. 17. The system of claim 15 , wherein the remote server is further configured to receive a patient identifier to associate the glucose data with the corresponding patient. 18. The system of claim 17 , wherein the patient identifier is encrypted. 19. The system of claim 15 , wherein the one or more processors and/or the remote server are configured to check for errors in the transmitted glucose data using cyclic redundancy checks. 20. The system of claim 10 , wherein the one or more data processing units comprise an application specific integrated circuit configured to implement one or more routines associated with the generation and/or storage and/or calibration and/or Bluetooth communication of the glucose data. 21. The system of claim 10 , wherein the operational status comprises an indication of system integrity. 22. The system of claim 10 , wherein the operational status comprises a duration of data collection. 23. The system of claim 10 , wherein the one or more data processing units comprise a Bluetooth transmitter.

Assignees

Inventors

Classifications

  • for data related to laboratory analysis, e.g. patient specimen analysis · CPC title

  • Apparatus provided with a docking unit · CPC title

  • for computer-aided diagnosis, e.g. based on medical expert systems · CPC title

  • for local operation · CPC title

  • Determining malfunction · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11264133B2 cover?
Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the st…
Who is the assignee on this patent?
Abbott Diabetes Care Inc
What technology area does this patent fall under?
Primary CPC classification G16H40/67. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).